chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3 days after vaccination - massive nose bleeds for 3 days straight with blood clots as large as my fingers.  And then sporadic nose bleeds in following months. Hadn?t had a nose bleed in 15-20 years.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-395985 (Patient Link).
Continued pain in the left arm. Some days it is a dull pain, some days it is intense pain.
Arm was baked in the sun; Dry; Flaky; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Arm was baked in the sun), DRY SKIN (Dry) and SKIN EXFOLIATION (Flaky) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     Concomitant products included VERAPAMIL for an unknown indication.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Arm was baked in the sun), DRY SKIN (Dry) and SKIN EXFOLIATION (Flaky). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 800 milligram. At the time of the report, FEELING HOT (Arm was baked in the sun), DRY SKIN (Dry) and SKIN EXFOLIATION (Flaky) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent. A 14 year-old male patient received bnt162b2 (BNT162B2), administration date 18Mar2022 (Batch/Lot number: unknown) as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose:1, MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (Dose:2, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: RASH (non-serious) with onset Mar2022, outcome "unknown", described as "Got rash on his stomach, back and groin areas/ just miscellaneous rash around his back, his torso and then his, in between his legs". Additional Context: Reporter stated, "Well myself and my 14-year-old son (Age was not further clarified hence, not captured in tab) got the Pfizer Booster shot so that would be our third shot, booster shot and I was reading the reaction paper, paper work with the reactions and all that and he's got a reaction to it, we got it last Friday so that I guess 10 days now and now he got rash on his stomach, back and groin areas but its not raised bumps or anything like that, but it is just miscellaneous rash around his back, his torso and then his, in between his legs but he said that it doesn't itch, its not sticking up, its not like a chicken pox or anything its, we just know if that reaction from the shot vaccine and if it is how long it is going to last?" Reporter stated, "No not right now." No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
There are no adverse reaction, the reason of this report is because the patient is under age (17 years old) at the moment of vaccination.
Nausea, headache, felt hot, throat felt tight/swollen. Patient was clammy and diaphoretic.
Immediately after injection: dizziness, nausea, light headedness,  temporary loss of hearing, blurred vision, abdominal cramps, fever.  1+ Hour after injection: severe abdominal cramps, nausea, severe headache (severe pain  behind eyes specially when eyes were open), chest pains, upper back pain, pain in all joints (primarily hips), muscle aches over whole body, fatigue, chills, fever, trouble breathing, light headedness  Morning After Injection: full body ache, severe fatigue, trouble sleeping, fever, chills,  body sweats, slight chest pains, even more severe headache.  24 -36 hours after Injection: reduced muscled aches, fatigue, headache, pain at the sight of injection.
33 y.o. female who arrived by on-campus presented to the emergency department for onset of dizziness and a splotchy red rash after receiving the COVID-19 vaccine today. Patient states after onset of her symptoms she further sat down for approximately 15 minutes, but when she went back up to work she was further prompted to come down to the ED for evaluation. Denies wheezing, nausea, or abdominal pain. Denies a history of allergies. Patient tested positive for COVID-19 at the end of this past September. No prior immunization reactions  Patient was given PO Benadryl and observed for one hour while here in the ED with no residual symptoms. Patient feels comfortable going home and will return for worsening symptoms. Will discharge patient with a prescription for Prednisone to use if symptoms return
This spontaneous report was received from a physician via company representative, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 13-MAY-2015, the patient was vaccinated with the improperly stored dose of PNEUMOVAX 23 "10 PK 0.5 ml SD-PFS LLok wTip" lot number K009106 with expiration date of 25-FEB-2016 (dose number, route of administration and anatomical location were not provided), which was stored at 1.11 Celsius Degrees for 88 hours and 0 Celsius Degrees for 40 hours. The type of excursion was refrigerator. No adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Upon admission to long-term care facility on 6/8/21 after inpatient hospitalization. Three COVID-19 vaccination cards were found in her wallet, stating that the patient had received three different COVID-19 vaccines in May 2021. She received one dose of the Pfizer-BioNTech vaccine (as reported above) on 5/6/21 (at CVS, but location unknown). She received one dose of the Janssen Johnson & Johnson vaccine on 5/11/21 (Lot# 1808980). She received one dose of the Moderna vaccine on 5/16/21 (Lot# 009C21A)" which is headquartered, CT. No signs/symptoms of complications noted.
Came into office for appt on 3/28/08 with a bruise at site of imunization left thigh. Yellow pus in center of bump, looked like an abcess. I&D of pustle with 10 cc of green pus expressed. Sent to Lab for C/S to r/o sterile abscess vs bacterial. Bandaid and warm compresses to be applied. C & S returned 3/31 was "no growth at 2 days. Spoke with mom, improved but still a small amount of pus came out. Afebrile.
Fatigue, muscle aches, headache, chills for about 24 hours and then very fatigued for the next day.
There is ongoing dull pain and some loss of range of motion in my left arm, which is the arm that was injected for my second dose. I thought this might be normal pain following the shot, but it persists more than 6 months after the shot.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On 20-May-2021, PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided Treatment information was not provided Once they received the shipment, the vaccines were placed at freezer temperature, at around -20 degree Celsius After that, a vial was removed from the freezer to administer vaccine. Doses that were viable up to 14-Apr-2021, the 30 days since it was thawed were administered to the patient beyond that day.
Anxiety; Shortness of breath; Shaking; Feeling hot and cold; Inappropriate schedule of vaccine administered; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), DYSPNOEA (Shortness of breath), TREMOR (Shaking), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cardiac disorder and Aortic aneurysm (surgery for aortic aneurism).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced ANXIETY (Anxiety) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). 30-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath), TREMOR (Shaking), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 30-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, ANXIETY (Anxiety), DYSPNOEA (Shortness of breath), TREMOR (Shaking), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Relevant concomitant medications included, Blood pressure medications, cholesterol medications and Nebulizers  were reported.   Treatment medications included cold compress.
05feb90 pt vax heptaB. 3 1/2 hrs later pt devel hives on face, neck and trunk and ex dizziness.  seen in er and treated w/ epinephrine and Dex. Next day pt given hepta B immune globulin.
Tingling and numbness from the bottom of my neck to the top of my head on the left side and the top 1/4 of my head on the right side. Numbness in my mouth and on the top of my tongue, but it did not affect my breathing or ability to speak. Swelling and tightness of my left cheek. The numbness/tingling lasted for 2-3 hours. The swelling lasted for about 3 full days. My mother called the Board of Health who said I should lay down. It helped. When I sat up, it started to spread again, so I laid down for about one hour. I later contacted my physician to see if I should get the 2nd shot.
Patient received Pfizer vaccine #2 today.    After the vaccine, the employee reported the following symptoms:  flush feeling.  She was already in her car.  She looked in the mirror and noted redness on her neck.  She then came back to the clinic.   redness on her neck and chest   Lot: EL3247  Time of Administration: 01/29/2021 1106am  Time Symptoms Began: 15-20+ minutes   _____   When arriving back in the clinic, she was taken to the medical observation area.    Initial Assessment @ _1141am_: Patient is AAO.  The employee sat on the sofa.  The employee is pink and does not appear to be in distress.  They are talking and making conversation. She has some redness on her neck.   Vitals @:1142  HR: 107  BP:  O2: 98   Given a water to drink.  NO itching, tingling, scratchy feeling.    Vitals @: 1145  HR: 94  BP:  O2:99    Allergies: Percocet.  Started as a rash on her chest.  Then she had facial swelling.  Was treated with prednisone.   No anaphylaxis ever.    Employee was discharged without treatment.  Advised to take a benadryl when she gets home.  She lives about 15 minutes from the clinic.
Site red continues to spread top of shoulder now red, hard and swollen worse daily instead of better. No fever since second day but site hot to touch
Central retinal venous occlusion in left eye.  Saw opthalmologist, retinal specialist, had eyelea injections. Approximately 90% of vision was gone and has not returned.
Menstrual cycle has completely stopped.  My last menstrual cycle was 28 August 2021.  I have not had a period since before my first COVID-19 vaccination.
This spontaneous prospective pregnancy report as received from a licensed practitioner nurse (LPN) refers to a 16 year old female patient with DILAUDID allergy. None of pertinent medical history was reported. On 22-MAY-2014 the pregnant patient was vaccinated with a dose of GARDASIL lot # J013324, expiry date 12-FEB-2016, 0.5 ml, intramuscular. Concomitant therapies included prenatal vitamins. The patient was currently almost two months pregnant. The patient's conception date was "about 29-APR-2014". The Last Menstrual Period (LMP) was approximately on 15-APR-2014 and Estimated Due Date (EDD) was 20-JAN-2015. No adverse effect reported. Patient did not seek medical attention and no treatment was given. None of lab diagnostics studies performed. The outcome of a event was unknown. Additional information has been requested.
DEVELOPED RT. SCIATIC PAIN/RT. RADICULOPATHY-SYMPTOMS ON SAME DAY AS AS SHE HAD THE TD
I felt great all day, so I was excited and then I felt like I got hit by bus, I had massive fatigue, fever 102.5, body aches, chills, and I had a horrible headache. the fever and headache lasted till Saturday morning. My fatigue lingered and out of breathe and I went to see my doctor. My doctor said my immune system over reacted. He gave me a steroid shot, he gave me a prednisone med dose  pack, I was better 36-48 hours after I saw the doctors.
Shaking and syncope.  Evalated legs, gave crackers and juice, stabilized patient.
warm, itchy injection site which is bigger than the size of a quarter; warm, itchy injection site which is bigger than the size of a quarter; This spontaneous report as received from a pharmacist refers to a 25-year-old female patient with no drug reactions or allergies and with no medical history. It was reported that the patient was not pregnant.  On 27-JUL-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (indication reported as "vaccine") (lot number: R024144; expiration date: 23-AUG-2020) (dose was not reported) which was reconstituted in a sterile diluent (lot number: R032352; expiration date: 04-JUN-2021; dose, formulation and route of administration were not provided). Concomitant medication included measles virus vaccine live (enders-edmonston) (+) mumps virus vaccine live (jeryl lynn) (+) rubella virus vaccine live (wistar ra 27/3) (M-M-R II).  On the same day, the patient had warm, itchy injection site which was bigger than the size of a quarter. The concomitant measles virus vaccine live (enders-edmonston) (+) mumps virus vaccine live (jeryl lynn) (+) rubella virus vaccine live (wistar ra 27/3) (M-M-R II) was administered on the same date in an opposite arm and the patient had no reaction at that injection site. The patient did not seek medical attention. There was no treatment given for the events. No laboratory diagnostics or studies were performed. The outcome of the events was reported as not recovered.  The relatedness between both suspects and the events was unknown.
hard lump on the injection site; he was noted to have redness; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (hard lump on the injection site), VACCINATION SITE ERYTHEMA (he was noted to have redness) and VACCINATION SITE SWELLING (swelling) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced VACCINATION SITE MASS (hard lump on the injection site), VACCINATION SITE ERYTHEMA (he was noted to have redness) and VACCINATION SITE SWELLING (swelling). At the time of the report, VACCINATION SITE MASS (hard lump on the injection site), VACCINATION SITE ERYTHEMA (he was noted to have redness) and VACCINATION SITE SWELLING (swelling) outcome was unknown.            No concomitant medications were reported. No treatment details were reported.
Patient had cough, throat swelling, rash on the lip and face 4 hours after received vaccine.
Arm was a little tender after injection; Hives; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Arm was a little tender after injection) and URTICARIA (Hives) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (Arm was a little tender after injection) and URTICARIA (Hives). At the time of the report, TENDERNESS (Arm was a little tender after injection) and URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Drs office called to report that child started talking non stop (not making sense) on the evening of 08/09/2005. Was taken to the hospital and admitted. Neurological evaluation has been ordered.
Bit of reaction on second night; rash on left body side; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Bit of reaction on second night) and RASH (rash on left body side) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029120A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ADVERSE REACTION (Bit of reaction on second night) and RASH (rash on left body side). At the time of the report, ADVERSE REACTION (Bit of reaction on second night) and RASH (rash on left body side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Feverish; Vomiting; Felt sore; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 03Apr2021 at 12:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Concomitant medications included ethinylestradiol/ levonorgestrel (AVIANE) pills taken for birth control from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 04Apr2021 at 00:00, 12 hours after the vaccination, the patient started to feel feverish and then started vomiting. The patient vomited every 10 to 15 minutes for the next 5 hours and could not keep down even water. The patient then felt sore and feverish for the next 15 hours. It was reported that the patient never heard or read of anyone with extensive vomiting as a symptom. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feverish, vomiting and felt sore was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Covid arm, swelling,  Itching, redness about 3 inch diameter. Hot to the touch.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with NAPROXEN SODIUM (ALEVE) for Pain, at an unspecified dose and frequency. On 15-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Inadvertantly administered the Covid-19 Moderna Bivalent 6m-5yr 0.2ml  instead of the  Covid-19 Moderna Primary Series 6m-5yr 0.25 ml Dose # 1
This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On 16-FEB-2018, the patient inadvertently received an expired dose of (Wistar RA 27-3) M-M-R II for prophylaxis, lot # M004305 and expiration date on 25-JAN-2018 (strength, dose number, anatomical location and route of administration were not reported), without adverse effect reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1807USA003048.